Sangamo Therapeutics Stock (NASDAQ: SGMO) stock price, news, charts, stock research, profile.
You can purchase shares of Sangamo Therapeutics (NASDAQ:SGMO) through any online brokerage.
Other companies in Sangamo Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and AnaptysBio (NASDAQ:ANAB).
Sangamo Therapeutics has a consensus price target of $5.36.
The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $2.41 last updated December 24, 2024 at 4:37 PM EST.
There are no upcoming dividends for Sangamo Therapeutics.
Sangamo Therapeutics’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
There is no upcoming split for Sangamo Therapeutics.
Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.